Variant report

Variant	nsv908224
Chromosome Location	chr17:38638251-38651447
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:642)
CpG islands
(count:183)
Chromatin interactive
region (count:42)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:642 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:38650565-38650684	K562	blood:	n/a	n/a
2	ATF1	chr17:38642368-38642677	K562	blood:	n/a	n/a
3	ATF3	chr17:38641926-38643376	A549	lung:	n/a	n/a
4	ATF3	chr17:38641488-38643532	A549	lung:	n/a	n/a
5	ATF3	chr17:38646699-38647460	A549	lung:	n/a	n/a
6	BCL3	chr17:38646268-38647219	A549	lung:	n/a	chr17:38646619-38646628
7	BCL3	chr17:38639720-38643973	A549	lung:	n/a	n/a
8	BCL3	chr17:38639648-38644407	A549	lung:	n/a	n/a
9	BCL3	chr17:38646038-38647168	A549	lung:	n/a	chr17:38646619-38646628
10	BHLHE40	chr17:38646724-38646865	K562	blood:	n/a	chr17:38646820-38646836
11	BHLHE40	chr17:38646089-38646215	GM12878	blood:	n/a	n/a
12	BHLHE40	chr17:38642511-38642607	K562	blood:	n/a	n/a
13	BRCA1	chr17:38643879-38643885	Hela-S3	cervix:	n/a	n/a
14	BRCA1	chr17:38642297-38643244	Hela-S3	cervix:	n/a	n/a
15	CBX3	chr17:38650373-38650785	K562	blood:	n/a	n/a
16	CBX3	chr17:38642222-38642696	K562	blood:	n/a	n/a
17	CEBPB	chr17:38646770-38647244	A549	lung:	n/a	chr17:38647037-38647048
18	CEBPB	chr17:38646736-38647218	IMR90	lung:	n/a	chr17:38647037-38647048
19	CEBPB	chr17:38646744-38647214	Hela-S3	cervix:	n/a	chr17:38647037-38647048
20	CEBPB	chr17:38642289-38643425	Hela-S3	cervix:	n/a	chr17:38642817-38642830
21	CEBPB	chr17:38642336-38643434	MCF-7	breast:	n/a	chr17:38642817-38642830
22	CEBPB	chr17:38650419-38650765	K562	blood:	n/a	n/a
23	CEBPB	chr17:38642346-38643327	ECC-1	luminal epithelium:	n/a	chr17:38642817-38642830
24	CEBPB	chr17:38645857-38646114	K562	blood:	n/a	n/a
25	CEBPB	chr17:38645884-38646051	A549	lung:	n/a	n/a
26	CEBPB	chr17:38641917-38643635	A549	lung:	n/a	chr17:38642817-38642830
27	CEBPB	chr17:38646809-38647243	ECC-1	luminal epithelium:	n/a	chr17:38647037-38647048
28	CEBPB	chr17:38642386-38642596	K562	blood:	n/a	n/a
29	CEBPB	chr17:38642337-38643456	ECC-1	luminal epithelium:	n/a	chr17:38642817-38642830
30	CEBPB	chr17:38650413-38650793	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr17:38646646-38647343	A549	lung:	n/a	chr17:38647037-38647048
32	CEBPB	chr17:38642377-38643349	HepG2	liver:	n/a	chr17:38642817-38642830
33	CEBPB	chr17:38642365-38643340	HepG2	liver:	n/a	chr17:38642817-38642830
34	CEBPB	chr17:38646808-38647202	A549	lung:	n/a	chr17:38647037-38647048
35	CEBPB	chr17:38646025-38646041	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr17:38645897-38646060	K562	blood:	n/a	n/a
37	CEBPB	chr17:38643025-38643266	K562	blood:	n/a	n/a
38	CEBPB	chr17:38645912-38646141	H1-hESC	embryonic stem cell:	n/a	n/a
39	CEBPB	chr17:38650425-38650745	K562	blood:	n/a	n/a
40	CEBPB	chr17:38642380-38643335	K562	blood:	n/a	chr17:38642817-38642830
41	CEBPB	chr17:38642302-38643390	A549	lung:	n/a	chr17:38642817-38642830
42	CEBPB	chr17:38646839-38647184	K562	blood:	n/a	chr17:38647037-38647048
43	CEBPB	chr17:38650442-38650724	A549	lung:	n/a	n/a
44	CEBPB	chr17:38650491-38650651	K562	blood:	n/a	n/a
45	CEBPB	chr17:38645910-38647310	ECC-1	luminal epithelium:	n/a	chr17:38647037-38647048
46	CEBPB	chr17:38646807-38647289	MCF-7	breast:	n/a	chr17:38647037-38647048
47	CEBPB	chr17:38646859-38647202	HepG2	liver:	n/a	chr17:38647037-38647048
48	CEBPB	chr17:38642379-38642864	K562	blood:	n/a	chr17:38642817-38642830
49	CEBPB	chr17:38642018-38643494	A549	lung:	n/a	chr17:38642817-38642830
50	CEBPB	chr17:38650425-38650761	IMR90	lung:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:38642659-38642709	T-47D	breast:	n/a
2	chr17:38648531-38648581	HCT-116	colon:	n/a
3	chr17:38648531-38648581	HAEpiC	amniotic membrane:	n/a
4	chr17:38646740-38646790	IMR90	lung:	fetal
5	chr17:38642659-38642709	GM12891	blood:	n/a
6	chr17:38642659-38642709	AG04450	lung:	fetal
7	chr17:38648531-38648581	GM12878	blood:	n/a
8	chr17:38648531-38648581	HMEC	breast:	n/a
9	chr17:38646740-38646790	GM12891	blood:	n/a
10	chr17:38642659-38642709	HEEpiC	esophagus:	n/a
11	chr17:38642659-38642709	AG09309	skin:	n/a
12	chr17:38648531-38648581	HRE	kidney:	n/a
13	chr17:38648531-38648581	RPTEC	kidney:	n/a
14	chr17:38642659-38642709	MCF-7	breast:	n/a
15	chr17:38646740-38646790	LNCaP	prostate:	n/a
16	chr17:38642659-38642709	PFSK-1	brain:	n/a
17	chr17:38646740-38646790	SK-N-SH_RA	brain:	n/a
18	chr17:38648531-38648581	GM19239	blood:	n/a
19	chr17:38648531-38648581	ProgFib	skin:	n/a
20	chr17:38648531-38648581	SK-N-MC	brain:	n/a
21	chr17:38642659-38642709	NH-A	brain:	n/a
22	chr17:38646740-38646790	PANC-1	pancreas:	n/a
23	chr17:38648531-38648581	HRCEpiC	kidney:	n/a
24	chr17:38642659-38642709	K562	blood:	n/a
25	chr17:38646740-38646790	PFSK-1	brain:	n/a
26	chr17:38646740-38646790	HEEpiC	esophagus:	n/a
27	chr17:38642659-38642709	RPTEC	kidney:	n/a
28	chr17:38642659-38642709	HMEC	breast:	n/a
29	chr17:38642659-38642709	ovcar-3	ovarian:	n/a
30	chr17:38648531-38648581	NHBE	bronchial:	n/a
31	chr17:38642659-38642709	HPAEpiC	pulmonary alveolar:	n/a
32	chr17:38642659-38642709	HCT-116	colon:	n/a
33	chr17:38642659-38642709	A549	lung:	n/a
34	chr17:38642659-38642709	HRCEpiC	kidney:	n/a
35	chr17:38648531-38648581	AG09309	skin:	n/a
36	chr17:38646740-38646790	HAEpiC	amniotic membrane:	n/a
37	chr17:38648531-38648581	HIPEpiC	eye:	n/a
38	chr17:38642659-38642709	GM12892	blood:	n/a
39	chr17:38648531-38648581	Caco-2	colon:	n/a
40	chr17:38642659-38642709	HEK293	kidney:	embryo
41	chr17:38646740-38646790	AG04449	skin:	fetal
42	chr17:38648531-38648581	ovcar-3	ovarian:	n/a
43	chr17:38642659-38642709	GM19239	blood:	n/a
44	chr17:38648531-38648581	MCF10A-Er-Src	breast:	n/a
45	chr17:38646740-38646790	SK-N-SH	brain:	n/a
46	chr17:38642659-38642709	HRPEpiC	eye:	n/a
47	chr17:38648531-38648581	A549	lung:	n/a
48	chr17:38648531-38648581	NHDF-neo	bronchial:	n/a
49	chr17:38642659-38642709	PrEC	prostate:	n/a
50	chr17:38648531-38648581	HPAEpiC	pulmonary alveolar:	n/a

(count:42 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:38645404..38649775-chr17:38650279..38653252,5	MCF-7	breast:
2	chr17:38643054..38644856-chr17:38668442..38670068,2	MCF-7	breast:
3	chr17:38642999..38645925-chr17:38647445..38650025,2	K562	blood:
4	chr17:38640893..38644463-chr17:38672113..38675330,4	MCF-7	breast:
5	chr17:38644489..38646400-chr17:38673085..38675357,2	K562	blood:
6	chr17:38640863..38643911-chr17:38644729..38647819,3	MCF-7	breast:
7	chr17:38648823..38651196-chr17:38668294..38669923,2	K562	blood:
8	chr17:38640900..38643857-chr17:38669358..38670867,2	MCF-7	breast:
9	chr17:38642763..38644324-chr17:38714423..38717219,2	K562	blood:
10	chr17:38643110..38644639-chr17:38644908..38646867,2	MCF-7	breast:
11	chr17:38640863..38643911-chr17:38644729..38647819,3	MCF-7	breast:
12	chr17:38636036..38638375-chr17:38656645..38659245,2	MCF-7	breast:
13	chr17:38650686..38654337-chr17:38656373..38659977,5	MCF-7	breast:
14	chr17:38641070..38642777-chr17:38643354..38644884,2	K562	blood:
15	chr17:38616795..38619778-chr17:38651196..38652807,2	K562	blood:
16	chr17:38641568..38644220-chr17:38656401..38660541,4	MCF-7	breast:
17	chr17:38639539..38641673-chr17:38677366..38679503,2	K562	blood:
18	chr17:38647398..38649761-chr17:38676727..38678938,2	K562	blood:
19	chr17:38641070..38642777-chr17:38643354..38644884,2	K562	blood:
20	chr17:38646024..38649623-chr17:38649808..38652805,4	K562	blood:
21	chr17:38642574..38644263-chr17:38714423..38716746,2	K562	blood:
22	chr17:38639003..38641951-chr17:38683883..38685651,2	MCF-7	breast:
23	chr17:38600534..38602477-chr17:38644496..38646702,2	K562	blood:
24	chr15:74218995..74221163-chr17:38641031..38642876,2	MCF-7	breast:
25	chr17:38645404..38649775-chr17:38650279..38653252,5	MCF-7	breast:
26	chr17:38640622..38642550-chr17:38663803..38666620,2	K562	blood:
27	chr17:38633817..38637978-chr17:38639202..38643004,3	K562	blood:
28	chr17:38638255..38640177-chr17:38640329..38642532,3	K562	blood:
29	chr17:38642192..38648064-chr17:38648142..38651157,5	K562	blood:
30	chr17:38597960..38600391-chr17:38643714..38646429,2	MCF-7	breast:
31	chr17:38599522..38602273-chr17:38649440..38651470,2	MCF-7	breast:
32	chr17:38632398..38634313-chr17:38645464..38649244,3	MCF-7	breast:
33	chr17:38645169..38647955-chr17:38652977..38654925,2	K562	blood:
34	chr17:38642192..38648064-chr17:38648142..38651157,5	K562	blood:
35	chr17:38643110..38644639-chr17:38644908..38646867,2	MCF-7	breast:
36	chr17:38646147..38648547-chr17:38673997..38676989,2	MCF-7	breast:
37	chr17:38640983..38649598-chr17:38652430..38659338,11	MCF-7	breast:
38	chr17:38634038..38637576-chr17:38640830..38643969,3	MCF-7	breast:
39	chr17:38650172..38654327-chr17:38654681..38657235,5	K562	blood:
40	chr17:38638255..38640177-chr17:38640329..38642532,3	K562	blood:
41	chr17:38642999..38645925-chr17:38647445..38650025,2	K562	blood:
42	chr17:38646024..38649623-chr17:38649808..38652805,4	K562	blood:

No data

Variant related genes	Relation type
TNS4	TF binding region
TNS4	CpG island
ENSG00000266088	chromatin interactions
ENSG00000261801	chromatin interactions
ENSG00000141753	chromatin interactions
ENSG00000131746	chromatin interactions

Extended variants
information (count: 560 )
Associated
traits (count: 120 )

Variant overlapped rSNPs/rCNVs (count:560 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs627857	chr17:38638251-38638252	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs56291600	chr17:38638260-38638261	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs569568992	chr17:38638277-38638278	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs71371428	chr17:38638299-38638300	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs370822072	chr17:38638322-38638323	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs558340230	chr17:38638367-38638368	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs202036554	chr17:38638391-38638392	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs371192811	chr17:38638404-38638405	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs112122797	chr17:38638411-38638412	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs148546882	chr17:38638432-38638433	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs534739496	chr17:38638439-38638440	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs201890192	chr17:38638441-38638442	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs552759932	chr17:38638453-38638454	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs574131575	chr17:38638473-38638474	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs376560646	chr17:38638481-38638482	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs369563494	chr17:38638491-38638492	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs112972414	chr17:38638492-38638493	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs114717573	chr17:38638530-38638531	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs534409647	chr17:38638538-38638539	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs368816872	chr17:38638547-38638548	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs575179203	chr17:38638569-38638570	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs532096092	chr17:38638573-38638574	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs201223141	chr17:38638576-38638577	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs545643734	chr17:38638607-38638608	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs142919679	chr17:38638626-38638627	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs151099469	chr17:38638628-38638629	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs528237877	chr17:38638630-38638631	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs140998686	chr17:38638644-38638645	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs554315271	chr17:38638645-38638646	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs147623676	chr17:38638646-38638647	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs373001993	chr17:38638685-38638686	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs376561311	chr17:38638687-38638688	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs115318855	chr17:38638695-38638696	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs529352319	chr17:38638718-38638719	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs577471409	chr17:38638721-38638722	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs540086424	chr17:38638722-38638723	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs533670622	chr17:38638723-38638724	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs551759035	chr17:38638724-38638725	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs567070641	chr17:38638725-38638726	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs142247926	chr17:38638733-38638734	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs553063199	chr17:38638750-38638751	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs556325427	chr17:38638794-38638795	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs367942938	chr17:38638837-38638838	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs200447557	chr17:38638838-38638839	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs567813612	chr17:38638869-38638870	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs372785902	chr17:38638871-38638872	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs377340800	chr17:38638872-38638873	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs535123165	chr17:38638875-38638876	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs556550631	chr17:38638891-38638892	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs574862353	chr17:38638913-38638914	Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:120)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Gastric cancer	24379144	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute myeloid leukemia	21251322	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Lung cancer	18438408	CNVD
Breast cancer	16620391	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22048815	CNVD
Breast cancer	17603634	CNVD
Follicular lymphoma	20505157	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	20953835	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Urothelial carcinoma	21177765	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
Disease	22962312	CNVD
Mental retardation	20152051	CNVD
Mental retardation	19951919	CNVD
Mental retardation	22817714	CNVD
Mental retardation	21956041	CNVD
Brain cancer	19584924	CNVD
Glioblastoma multiforme	22286061	CNVD
Schizophrenia	21399695	CNVD
Non-syndromic sensorineural hearing loss	19165922	CNVD
Prader-willi syndrome	20588305	CNVD
17q21.31 microdeletion syndrome	16940994	CNVD
Non-syndromic sensorineural hearing loss	21084979	CNVD
17q21.31 microdeletion syndrome	22283845	CNVD
Intellectual disability	22194194	CNVD
17q21.31 microdeletion syndrome	20606400	CNVD
17q21.31 microdeletion syndrome	18628315	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
TAR Syndrome	17847015	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17850661	CNVD
Breast cancer	19261255	CNVD
Lung cancer	16773561	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Basal-like breast cancer	18066063	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Hereditary breast	19566914	CNVD
Ovarian cancer	19047089	CNVD
Ovarian cancer	19566914	CNVD
Triple-negative breast cancer	18950515	CNVD
Breast cancer	16846527	CNVD
Human papillomavirus	17975027	CNVD
Breast cancer	19767729	CNVD
Breast cancer	20409316	CNVD
Medulloblastoma	16783165	CNVD
Bladder cancer	21909424	CNVD
Intracranial arachnoid cysts	20187927	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:605 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:38627400-38646200	Weak transcription	Gastric	stomach
2	chr17:38631800-38639600	Enhancers	Primary B cells from peripheral blood	blood
3	chr17:38632000-38639200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
4	chr17:38632400-38639200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
5	chr17:38632400-38641000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr17:38632800-38641000	Weak transcription	Osteobl	bone
7	chr17:38633000-38641000	Weak transcription	NHLF	lung
8	chr17:38633400-38643800	Weak transcription	Right Ventricle	heart
9	chr17:38634000-38639400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
10	chr17:38634200-38639800	Enhancers	Primary T helper cells fromperipheralblood	blood
11	chr17:38635200-38638600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
12	chr17:38635600-38639400	Enhancers	Primary B cells from cord blood	blood
13	chr17:38635800-38638600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
14	chr17:38635800-38638800	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr17:38635800-38638800	Enhancers	HepG2	liver
16	chr17:38635800-38641800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr17:38636000-38647000	Genic enhancers	Breast Myoepithelial Primary Cells	Breast
18	chr17:38636000-38648200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr17:38636000-38649600	Genic enhancers	HMEC	breast
20	chr17:38636200-38638600	Enhancers	HUES6 Cell Line	embryonic stem cell
21	chr17:38636400-38638400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
22	chr17:38636400-38639200	Enhancers	Stomach Mucosa	stomach
23	chr17:38636400-38639600	Enhancers	Rectal Mucosa Donor 31	rectum
24	chr17:38636600-38639400	Enhancers	Primary hematopoietic stem cells short term culture	blood
25	chr17:38636600-38639400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
26	chr17:38636600-38642600	Weak transcription	Right Atrium	heart
27	chr17:38636800-38642000	Genic enhancers	Hela-S3	cervix
28	chr17:38637000-38638600	Transcr. at gene 5' and 3'	A549	lung
29	chr17:38637000-38639400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
30	chr17:38637000-38640000	Weak transcription	HUES64 Cell Line	embryonic stem cell
31	chr17:38637000-38640000	Enhancers	Primary T helper cells PMA-I stimulated	--
32	chr17:38637000-38640200	Weak transcription	HUES48 Cell Line	embryonic stem cell
33	chr17:38637000-38640800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr17:38637000-38640800	Weak transcription	Skeletal Muscle Female	skeletal muscle
35	chr17:38637000-38641000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
36	chr17:38637000-38643400	Enhancers	K562	blood
37	chr17:38637000-38644800	Genic enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr17:38637200-38638600	Genic enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr17:38637200-38639200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr17:38637200-38639400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
41	chr17:38637200-38639800	Weak transcription	Placenta Amnion	Placenta Amnion
42	chr17:38637200-38641000	Weak transcription	NH-A	brain
43	chr17:38637200-38641200	Enhancers	Primary T cells fromperipheralblood	blood
44	chr17:38637200-38642000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
45	chr17:38637400-38638600	Genic enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr17:38637400-38638600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
47	chr17:38637400-38639200	Enhancers	Primary T helper naive cells from peripheral blood	blood
48	chr17:38637400-38640200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
49	chr17:38637400-38641000	Weak transcription	HSMM	muscle
50	chr17:38637400-38642000	Strong transcription	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links